Answers are grounded in this paper and cite their sources.
Randomized trial shows fluoxetine effectively treats major depression in outpatients, suggesting a promising option.
In a double-blind, placebo-controlled study the authors found that fluoxetine, a potent and selective inhibitor of serotonin reuptake, was an effective antidepressant in moderately depressed, ambulatory outpatients. Typical adverse effects reported by patients treated with fluoxetine included agitation, nausea, fatigue, and insomnia. Compared to imipramine, fluoxetine was associated with fewer complaints of dry mouth, constipation, and dizziness.
No takes yet. Share an insight, caveat, or question.
Byerley et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: